Controlled and Selective Photo-oxidation of Amyloid-β Fibrils by Oligomeric p-Phenylene Ethynylenes
- 28 March 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (13) , 14871-14886
Abstract
Photodynamic therapy (PDT) has been explored as a therapeutic strategy to clear toxic amyloid aggregates involved in neurodegenerative disorders such as Alzheimer’s disease. A major limitation of PDT is off-target oxidation, which can be lethal for the surrounding cells. We have shown that a novel class of oligo-p-phenylene ethynylenes (OPEs) exhibit selective binding and fluorescence turn-on in the presence of prefibrillar and fibrillar aggregates of disease-relevant proteins such as amyloid-β (Aβ) and α-synuclein. Concomitant with fluorescence turn-on, OPE also photosensitizes singlet oxygen under illumination through the generation of a triplet state, pointing to the potential application of OPEs as photosensitizers in PDT. Herein, we investigated the photosensitizing activity of an anionic OPE for the photo-oxidation of Aβ fibrils and compared its efficacy to the well-known but nonselective photosensitizer methylene blue (MB). Our results show that, while MB photo-oxidized both monomeric and fibrillar conformers of Aβ40, OPE oxidized only Aβ40 fibrils, targeting two histidine residues on the fibril surface and a methionine residue located in the fibril core. Oxidized fibrils were shorter and more dispersed but retained the characteristic β-sheet rich fibrillar structure and the ability to seed further fibril growth. Importantly, the oxidized fibrils displayed low toxicity. We have thus discovered a class of novel theranostics for the simultaneous detection and oxidization of amyloid aggregates. Importantly, the selectivity of OPE’s photosensitizing activity overcomes the limitation of off-target oxidation of traditional photosensitizers and represents an advancement of PDT as a viable strategy to treat neurodegenerative disorders.Keywords
All Related Versions
Funding Information
- National Institute of Neurological Disorders and Stroke (1R21NS111267-01)
- Division of Engineering Education and Centers (1560058)
- Defense Threat Reduction Agency (HDTRA1-08-1-0053)
- Division of Chemical, Bioengineering, Environmental and Transport Systems (1605225)
- National Institute of General Medical Sciences (5R25GM075149)
- Division of Materials Research (1207362)
This publication has 88 references indexed in Scilit:
- Trans-cellular Propagation of Tau Aggregation by Fibrillar SpeciesJournal of Biological Chemistry, 2012
- Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease BrainJournal of Biological Chemistry, 2011
- The R.E.D. tools: advances in RESP and ESP charge derivation and force field library buildingPhysical Chemistry Chemical Physics, 2010
- Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrilsProceedings of the National Academy of Sciences, 2008
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008
- Characterization of the nanoscale properties of individual amyloid fibrilsProceedings of the National Academy of Sciences, 2006
- Physiological roles for amyloid β peptidesThe Journal of Physiology, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004